Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer
The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities
Kinetic stabilization of microtubule dynamics by indanocine perturbs EB1 localization, induces defects in cell polarity and inhibits migration of MDA-MB-231 cells
Covalent binding of cisplatin impairs the function of Na+/K+-ATPase by binding to its cytoplasmic part
Minor structural modifications to alchemix influence mechanism of action and pharmacological activity
The inhibitory glutathione transferase M2–2 binding site is located in divergent region 3 of the cardiac ryanodine receptor
Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels
3-(4-( tert -Octyl)phenoxy)propane-1,2-diol suppresses inflammatory responses via inhibition of multiple kinases
Novel fluorescent antagonist as a molecular probe in A3 adenosine receptor binding assays using flow cytometry
Characterisation of Nav types endogenously expressed in human SH-SY5Y neuroblastoma cells
Changes in morphine-induced activation of cerebral Na+,K+-ATPase during morphine tolerance: Biochemical and behavioral consequences